
Treatment approaches for restless legs syndrome including iron supplementation, dopaminergic agents, alpha-2-delta ligands, and behavioral strategies.
Restless legs syndrome (RLS) treatment aims to relieve the uncomfortable urge to move the legs that occurs at rest and in the evening. Treatment begins with identifying and correcting underlying causes, particularly iron deficiency. When iron is adequate, medications including alpha-2-delta ligands (gabapentin, pregabalin) and dopaminergic agents can provide relief. Treatment choice depends on symptom frequency, severity, and patient factors. Behavioral strategies complement medical treatment.
Iron supplementation corrects deficiency that contributes to RLS in many patients. Alpha-2-delta ligands reduce nerve excitability and are first-line for daily symptoms. Dopaminergic agents (dopamine agonists, occasionally levodopa) increase dopamine activity, relieving RLS but carrying risk of augmentation with long-term use. Opioids may be used for severe, refractory cases.
Patients with RLS symptoms that significantly affect sleep or quality of life should consider treatment. Those with infrequent, mild symptoms may manage with behavioral strategies alone, while frequent or severe symptoms typically require medication.
Effective treatment substantially reduces or eliminates the uncomfortable sensations and urge to move that characterize RLS.
With RLS symptoms controlled, patients fall asleep more easily and sleep more restfully.
Treatment allows patients to sit comfortably, enjoy sedentary activities, travel, and function without constant leg discomfort.
Many RLS patients have periodic limb movements of sleep (PLMS). RLS treatment often reduces these as well.
Various effective treatments exist, so if one doesn't work or causes problems, alternatives are available.
Most side effects are minor and can often be resolved with simple adjustments.
Long-term dopamine agonist use can cause augmentation—symptoms becoming worse and starting earlier. This is a significant concern.
Dopamine agonists can cause compulsive behaviors (gambling, shopping, eating) in some patients.
Gabapentin and pregabalin can cause drowsiness, dizziness, weight gain, and cognitive effects.
Iron can cause constipation, nausea, and stomach upset. IV iron may be needed if oral iron isn't tolerated or effective.
When opioids are needed for severe RLS, they carry risks of dependence, constipation, and sedation.
First step for patients with low iron stores (ferritin <75). Oral or IV iron can significantly improve or resolve RLS.
Gabapentin enacarbil (Horizant), gabapentin, and pregabalin are first-line for daily symptoms. Don't cause augmentation.
Pramipexole and ropinirole are effective but carry augmentation risk. Best used at lowest effective dose for limited periods.
For severe, refractory RLS, low-dose opioids can be effective when other treatments fail.
Counter-stimulation (massage, stretching), mental alerting activities, sleep hygiene, and avoiding triggers can help manage symptoms.
Request iron studies including ferritin. Even 'normal' ferritin below 75 may contribute to RLS. Treating iron deficiency can be curative.
Alcohol, caffeine, antihistamines, and some antidepressants can worsen RLS. Identify and minimize your triggers.
Regular moderate exercise often helps RLS. Avoid intense exercise close to bedtime.
If prescribed dopamine agonists, use lowest effective dose and watch for augmentation (symptoms worsening, spreading, or starting earlier).
Leg massage, hot or cold compresses, stretching, or walking can provide temporary relief during symptom flares.
If symptoms change—become more severe, spread to arms, start earlier in the day—report to your provider. This may indicate augmentation.
Search our directory for sleep clinics that offer restless legs syndrome treatment.
Search Clinics